Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Parkinson's Disease

  Free Subscription


15.03.2021

1 Brain Res
1 Exp Brain Res
1 Exp Neurol
2 Mov Disord
1 Nature
2 Neurobiol Dis
1 Neurosci Lett
1 PLoS Comput Biol
1 PLoS One
1 Rev Neurol


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Brain Res

  1. FERNANDEZ-ESPEJO E, Rodriguez de Fonseca F, Suarez J, Martin de Pablos A, et al
    Cerebrospinal fluid lactoperoxidase level is enhanced in idiopathic Parkinson's disease, and correlates with levodopa equivalent daily dose.
    Brain Res. 2021 Mar 4:147411. doi: 10.1016/j.brainres.2021.147411.
    PubMed         Abstract available


    Exp Brain Res

  2. CRESSMAN EK, Salomonczyk D, Constantin A, Miyasaki J, et al
    Proprioceptive recalibration following implicit visuomotor adaptation is preserved in Parkinson's disease.
    Exp Brain Res. 2021 Mar 10. pii: 10.1007/s00221-021-06075.
    PubMed         Abstract available


    Exp Neurol

  3. SIMMNACHER K, Krach F, Schneider Y, Alecu JE, et al
    Unique signatures of stress-induced senescent human astrocytes.
    Exp Neurol. 2020;334:113466.
    PubMed         Abstract available


    Mov Disord

  4. DOBKIN RD, Mann SL, Weintraub D, Rodriguez KM, et al
    Innovating Parkinson's Care: A Randomized Controlled Trial of Telemedicine Depression Treatment.
    Mov Disord. 2021 Mar 12. doi: 10.1002/mds.28548.
    PubMed         Abstract available

  5. CHOHAN H, Senkevich K, Patel RK, Bestwick JP, et al
    Type 2 Diabetes as a Determinant of Parkinson's Disease Risk and Progression.
    Mov Disord. 2021 Mar 8. doi: 10.1002/mds.28551.
    PubMed         Abstract available


    Nature

  6. WILLYARD C
    How gut microbes could drive brain disorders.
    Nature. 2021;590:22-25.
    PubMed        


    Neurobiol Dis

  7. ZOU L, Zhang X, Xiong M, Meng L, et al
    Asparagine endopeptidase cleaves synaptojanin 1 and triggers synaptic dysfunction in Parkinson's disease.
    Neurobiol Dis. 2021 Mar 4:105326. doi: 10.1016/j.nbd.2021.105326.
    PubMed         Abstract available

  8. CHU Y, Kordower JH
    GDNF signaling in subjects with minimal motor deficits and Parkinson's disease.
    Neurobiol Dis. 2021 Mar 5:105298. doi: 10.1016/j.nbd.2021.105298.
    PubMed         Abstract available


    Neurosci Lett

  9. NAUSHAD SM, Hussain T, Alrokayan S, Kutala VK, et al
    Alpha synuclein (SNCA) rs7684318 variant contributes to Parkinson's disease risk by altering transcription factor binding related with Notch and Wnt signaling.
    Neurosci Lett. 2021 Mar 8:135802. doi: 10.1016/j.neulet.2021.135802.
    PubMed         Abstract available


    PLoS Comput Biol

  10. STAMATE C, Saez Pons J, Weston D, Roussos G, et al
    PDKit: A data science toolkit for the digital assessment of Parkinson's Disease.
    PLoS Comput Biol. 2021;17:e1008833.
    PubMed         Abstract available


    PLoS One

  11. PHAM U, Skogseid IM, Pripp AH, Boen E, et al
    Impulsivity in Parkinson's disease patients treated with subthalamic nucleus deep brain stimulation-An exploratory study.
    PLoS One. 2021;16:e0248568.
    PubMed         Abstract available


    Rev Neurol

  12. MANEZ-MIRO JU, Vivancos-Matellano F, Wetmore J, Martinez-Martin P, et al
    [Pilot study of a new tool to optimise dopaminergic treatment in Parkinson's disease: the OPTIMIPARK questionnaire].
    Rev Neurol. 2021;72:179-186.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: